Cardioprotection Afforded by SUR2A: An Update

Journal Title: Journal of Cardiobiology - Year 2013, Vol 1, Issue 2

Abstract

SUR2A is an atypical ABC protein serving as a regulatory subunit of ATP-sensitive K+ (KATP) channels. In experimental animals, it has been found that an increase in myocardial level of this protein protects the heart against different types of metabolic stresses, including ischaemia. Increase in SUR2A leads to increase in number of fully-assembled KATP channels, which is associated with earlier channel activation during ischaemia as well as increased production of ATP by enzymes that are physically associated with the channel subunits. Activation of KATP channels shorten action membrane potential to prevent Ca2+ influx while ATP production increases subsarcolemmal ATP levels providing energy for vital energydependent processes at this localisation. The most recent findings are that SUR2A might also regulate expression of genes that are important in cardioprotection. How to increase SUR2A expression in an efficient and safe manner has been considered. Two possible approaches have been found to be promising. One is gene therapy approach with adenovirus containing SUR2A which was successful at the cellular level and the other was oral nicotinamide, a form of vitamin B3, which was efficient under ex vivo conditions. Based on all these findings, we believe that SUR2A-based strategies against heart ischaemia deserve to be further elucidated and tested. A therapy of ischaemic heart disease exploiting endogenous cardioprotective factors, including SUR2A, would be an excellent adjunct to current therapeutic strategies of ischaemic heart disease and other cardiovascular diseases where increase in cardiac resistance to stress would be beneficial.

Authors and Affiliations

Aleksandar Jovanović

Keywords

Related Articles

Different Role of Left Atrial Size and Function in Patients with Paroxysmal versus Persistent Atrial Fibrillation. Wellnhofer: LA Size & Function in Atrial Fibrillation

Purpose: Pulmonary vein isolation (PVI) is established as interventional treatment in atrial fibrillation (AF). Recent studies suggest that atrial reservoir function (preload) is involved in initiation of paroxysmal AF (...

CRT-P Implantation and Consecutive AV-node Ablation as Rescue Therapy for Refractory Atrial Fibrillation: A Single Center Experience

Aims: Cardiac resynchronization therapy (CRT-P) and atrioventricular node (AVN) ablation are a recommended treatment option for patients with atrial fibrillation (AF) refractory to medical treatment or pulmonary vein iso...

Sick Sinus Syndrome Induced by Giant Coronary Artery Aneurysm Rupture in a Patient with Constrictive Pericarditis

Multiple coronary artery aneurysms (CAA) with a giant CAA are rare. Patient with a giant CAA is at risk of thrombosis, aneurysm rupture and even sudden cardiac death. We reported a case of a 78-year-old woman having a gi...

An Unusual Presentation of a 15-Year-Old Adolescence with Invasive Breast Cancer

A 15 year-old girl of Bangladesh decent presented with a 2-month history of a left breast mass associated with pain and spontaneous bloody nipple discharge. She was otherwise healthy and on no regular medications. With r...

Delayed Cardiac Injury from Gradual Bullet Fragment Erosion into the Right Ventricle

Penetrating cardiac injuries are among the most lethal of all traumatic injuries, with many studies citing mortalities of 70-90% [1-3]. Such injuries account for a very small proportion of annual trauma admissions (0.1%)...

Download PDF file
  • EP ID EP194344
  • DOI 10.13188/2332-3671.1000001
  • Views 95
  • Downloads 0

How To Cite

Aleksandar Jovanović (2013). Cardioprotection Afforded by SUR2A: An Update. Journal of Cardiobiology, 1(2), 1-4. https://europub.co.uk/articles/-A-194344